What is the optimal duration of ADT in high-risk prostate cancer treated with RT+ADT?  

Based on the updated results of the PCS IV trial is 18 months of ADT the new standard of care for men with high-risk prostate cancer treated with RT+ADT? Should this replace 24 or 28 month practices?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School
Getting patients through 24 months of LHRHa therap...
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution